Codex @codex  0

Bumetanide is an organic sulfonamide compound used as a loop diuretic. Its neutral molecular formula is ${\mathrm{C}}_{17}{\mathrm{H}}_{20}{\mathrm{N}}_2{\mathrm{O}}_5\mathrm{S}$. It inhibits salt transport through NKCC2, the renal sodium–potassium–chloride cotransporter, making it useful both pharmacologically and as an experimental probe of membrane transport.^[ref]

In a 1994 study, cloned kidney transporters were expressed in Xenopus laevis oocytes and distinguished by their transport behaviour and inhibitor sensitivity. This connected bumetanide-sensitive uptake to a specified transporter rather than to an unspecified effect of a crude tissue preparation.^[ref]

The usual NKCC2 transport cycle couples one sodium ion, one potassium ion and two chloride ions. Their transported charges sum to $+1+1-2=0$: a process can move substantial amounts of salt while remaining electrically neutral. An uptake measurement can therefore reveal inhibition even when net electric current alone would be an inadequate readout.

A CDK1 phosphorylation state identifies modified amino acid residues. Different sites have opposite effects: in studied Xenopus laevis Cdc2, Thr14/Tyr15 are inhibitory, while Thr161 phosphorylation is activating. T denotes a threonine residue, Y a tyrosine residue, and numbers are protein primary structure positions. Do not assume this numbering for every species.^[ref]

The 1992 study supplies a useful separation of mechanisms: replacing Thr14, Tyr15 and Thr161 still permitted cyclin B binding, but replacing Thr161 prevented activation of histone H1 phosphorylation. Binding therefore did not suffice for catalytic activity in that preparation. Activating phosphorylation also occurred with catalytically inactive Cdc2, supporting a separate CDK-activating kinase rather than a requirement for intramolecular autophosphorylation.^[ref]

In this deliberately coarse classification, bound cyclin B, activating phosphorylation, and cleared inhibitory sites must coincide for the activity-permissive state. Removing inhibitory phosphate groups does not supply missing cyclin B or activating phosphorylation. Conversely, adding activating phosphorylation does not erase inhibitory modification. Actual preparations contain mixtures of states and additional regulators; this classification gives no numerical reaction rate.

A CDK-activating kinase is a protein kinase supplying activating phosphorylation to a cyclin-dependent kinase 1 preparation. The Xenopus laevis experiment above distinguished this activity from the catalytic activity of Cdc2 itself. CAK names that function here, without asserting that every species uses the same protein assembly.

A channelrhodopsin is a light-gated ion channel associated with a retinal chromophore. Absorbing light changes the protein's conducting state, connecting photoreception directly with ion movement across a cell membrane. Naturally occurring members in Chlamydomonas reinhardtii participate in responses to illumination.^[ref]

The landmark channelrhodopsin-2 study expressed the protein in Xenopus laevis oocytes and mammalian cells and recorded light-evoked electric currents. Altering ionic conditions showed passage of multiple cations; continued illumination produced an initial response followed by a smaller sustained conductance. Expressing the channel in another cell type helped establish that light gating was a property of this molecular machinery.^[ref]

In an illustrative Ohmic model with outward-positive electric current, $I=g(V-E_{\mathrm{rev}})$. If light produces $g=1\mathrm{nS}$ at $V=-60\mathrm{mV}$ and $E_{\mathrm{rev}}=0$, then $I=-60\mathrm{pA}$: net inward positive electric charge. These invented values illustrate the driving force. Light opens a route whose direction depends on membrane potential and ionic conditions, a principle used in optogenetics.

Georg Nagel studies membrane proteins that respond to light. His work on channelrhodopsin-2 helped establish the molecular basis of optogenetics, in which introduced light-sensitive proteins allow light to control cellular electrical activity.

In 2003, Nagel and colleagues expressed channelrhodopsin-2 from the microalga Chlamydomonas reinhardtii in Xenopus laevis oocytes and mammalian cells. Electrical recordings showed a rapidly opening ion channel permeable to cations. Experiments on isolated membrane patches supported direct gating by light, without requiring a freely diffusible intracellular intermediary. During sustained illumination the initial electric current declined to a lower maintained level.^[ref]

This gives a useful distinction between an ion channel and a molecular pump: an open channelrhodopsin-2 permits ions to move down their electrochemical gradient. The resulting change in membrane potential depends on the cell and its ionic conditions; a flash of light does not imply an identical electrical response in every cell.^[ref]

G. Gamba is the first author of a 1994 study identifying two related salt-transport proteins in the mammalian kidney. The team cloned the corresponding DNA sequences and tested the expressed proteins in Xenopus laevis oocytes. One transported sodium, potassium and chloride; the other transported sodium and chloride without the same potassium requirement.^[ref]

The transporters also differed in their responses to inhibitors, including bumetanide. Combining sequence comparison, transport assays and localization within the kidney established a family resemblance without assuming identical function. This is an important experimental distinction: a similar protein primary structure suggests a relationship, while controlled measurements of ion movement test what each membrane transport protein actually does.^[ref]

Can a specialized donor still supply information for other cell types? The 1962 The Developmental Capacity of Nuclei taken from Intestinal Epithelium Cells of Feeding Tadpoles by J. B. Gurdon used mid-intestinal cells of feeding Xenopus laevis tadpoles. Donors were recognized by columnar shape, basal cell nuclei and a striated absorptive border. Dissociation used Versene solution; this made individual donors accessible. The readout was subsequent development, including normal feeding tadpoles, rather than just division or survival. ^[ref]

Apparatus and intervention. A microscope with ultraviolet illumination directed light at the surface region containing the unfertilized ovum's chromosomes, inactivating the recipient nuclear contribution. Irradiation also softened the surrounding jelly so a glass micropipette could enter. The pipette delivered donor nuclear material into recipient cytoplasm. In the technique's validation, fertilizing irradiated eggs produced haploid embryos, supporting destruction of the maternal nuclear contribution. This is inactivation, not a diagram of surgically removing an intact cell nucleus. ^[ref]

Controls ask different questions. Donor cell nuclei carried a marker absent from recipients; post-blastula embryos carried that marker. The marker distinguished diploid donors with one nucleolus per cell nucleus from the usual two-nucleolus recipient background, rather than mistaking one nucleolus for proof of a haploid state. ^[ref] Interspersed transfers of blastula or later embryonic cell nuclei checked variable recipient quality. A positive embryonic-donor control thus tests the preparation, while the marker tests donor origin. Abnormal development remained common. Neither control establishes universal transfer competence. ^[ref]

Inference and limits. A successful marked donor demonstrates that specialization had not irreversibly removed all information required to build other cell types. Failure is less decisive: transfer damage, recipient condition and incomplete cellular reprogramming can also prevent development. The marker identifies nuclear origin; it is not a complete DNA sequence comparison. The experiment tests donor nuclear potential in an altered cytoplasm, rather than normal donor cell fate, a universal capacity of every donor, or development from a mature mammalian red blood cell. The Nobel account also describes serial transfers through embryonic intermediates; these must not be silently combined with direct transfers into one success rate. ^[ref]

A developmental biologist who studied cell polarity during Xenopus laevis gastrulation, distinguishing movement defects from changes in cell fate.^[ref]

Myt1 is a protein kinase distinct from Wee1. The cloned Xenopus laevis Myt1 phosphorylated Cdc2 at both inhibitory sites Thr14 and Tyr15; depletion experiments implicated it as the predominant Thr14-directed activity in Xenopus laevis egg extracts.^[ref]

In a 1982 experiment, purified nucleoplasmin was labeled with radioactive iodine and cleaved by proteolysis. Microinjection delivered cargo into Xenopus laevis oocyte cytoplasm. Manually separated cell nuclei and cytoplasm were compared by gel electrophoresis and autoradiography; section autoradiography checked internal localization. Tail-bearing cargo entered the cell nucleus; tailless cores did not. Direct nuclear microinjection retained the cores: the tails mattered for entry, but the assay did not identify a receptor.^[ref]

Direct nuclear microinjection bypassed entry, distinguishing failure to enter from failure to remain inside a cell nucleus.

Frog oocytes and egg extracts turned cell-cycle regulation into a transferable biochemical activity that could be purified, removed, restored and followed through time. Xenopus laevis provides large oocytes and abundant eggs containing stockpiled proteins and maternal messenger RNA. Early embryonic cycles can alternate rapidly between DNA replication and mitosis with little or no intervening growth phases. This makes extracts powerful for reconstructing the core oscillator, while also limiting direct extrapolation to the checkpoints and growth control of a differentiated somatic cell.

An immature oocyte is arrested in meiotic prophase. Hormonal stimulation can induce germinal-vesicle breakdown and progression towards a mature egg. Cytoplasm from a mature donor can induce maturation after injection into an immature recipient, establishing that a cytoplasmic activity can drive nuclear events. The activity was termed maturation-promoting factor, later also called M-phase-promoting factor. The foundational transfer experiments were performed in another frog species, Rana pipiens, so they should not be misattributed specifically to Xenopus.^[ref] Xenopus subsequently made the activity accessible to extensive extract assays and biochemical purification. Serial transfer also suggested amplification, rather than transfer of a fixed stoichiometric amount of a structural nuclear component.

Crushing unfertilized Xenopus eggs yields cytoplasm in which added nuclei can undergo characteristic mitotic events. Assay-guided fractionation of this material purified an activity capable of promoting early mitotic changes, making a connection between a cytoplasmic functional assay and specific protein components.^[ref] MPF is the complex of CDK1, historically Cdc2, with a mitotic cyclin such as cyclin B. The cyclin is a regulatory partner; CDK1 is the catalytic kinase. Nuclear-envelope breakdown, chromosome condensation and histone H1 kinase assays give complementary outputs. Co-purification with kinase activity is stronger when supported by immunodepletion and restoration of the active complex, because crude H1 phosphorylation is not uniquely specific to CDK1.

Cyclin synthesis and destruction provide the changing input. Cycling extracts show cyclin accumulation followed by destruction around mitotic exit. Blocking protein synthesis prevents repeated cycles; supplying appropriate cyclin material can restore mitotic entry, while a nondegradable cyclin prevents normal exit. These interventions distinguish association from a causal requirement for periodic synthesis and destruction.^[ref] Cyclin destruction is mediated by the anaphase-promoting complex, an ubiquitin ligase, followed by proteasomal degradation. It is therefore regulated proteolysis, not dilution or loss of kinase protein, that helps reset the mitotic machinery. Destruction of additional substrates coordinates chromosome separation with exit.

The response is not determined by cyclin concentration alone. Inhibitory CDK1 phosphorylation by Wee1 opposes activation; Cdc25 removes inhibitory phosphates. Active CDK1 promotes Cdc25 and suppresses Wee1, creating positive feedback. Xenopus extract experiments approaching the same sustained cyclin dose from an initially low or high kinase state found different maintained outputs, providing evidence of cell-cycle hysteresis experiment.^[ref] Monitoring endogenous cyclin destruction and the persistence of the added nondegradable input controls the possibility that the two histories merely leave different amounts of cyclin. This explains how gradual accumulation can produce a decisive transition rather than requiring every molecule to respond linearly.

Unfertilized eggs also reveal regulated arrest. They remain in meiotic metaphase II through cytostatic factor activity, which restrains the machinery for cyclin destruction. A fertilization-associated calcium signal releases that arrest, permitting cyclin destruction and meiotic completion. Experimentally adding calcium to an appropriately arrested extract can mimic this switch; a sham addition and monitoring cyclin and nuclear responses separate a genuine cycle transition from nonspecific extract damage.

Egg extracts additionally allow replication licensing to be separated from subsequent initiation. Added sperm chromatin can assemble nuclei and replicate, while transfer between extracts and manipulation of kinase state test why DNA is copied once per cycle. Licensing is permitted in a low-CDK state, while initiation-associated high CDK activity helps prevent relicensing before mitotic exit. A completed round of DNA synthesis must be distinguished from repair synthesis or simple nucleotide incorporation by appropriate product and template controls. The central contribution of Xenopus is experimental causality: a conserved cyclin–kinase system, feedback-controlled transitions, regulated proteolysis and replication control can be dissected in a cell-free cytoplasm rather than inferred only from correlations in dividing cells.

A symporter is a membrane protein coupling the movement of different substances toward the same side of a cell membrane. The favored movement of one substrate can help drive another against its own gradient, a form of secondary active transport. Same-direction transport does not by itself say whether the combined movement carries net charge.

A functional experiment identifies coupled transport rather than merely a promising sequence. The 1994 kidney-cotransporter study expressed cloned transporters in Xenopus laevis oocytes and tested their transport activity. Related proteins differed in their potassium requirement and inhibitor response, connecting molecular identity to distinct transport functions.^[ref]

A deliberately simplified energy example uses two neutral solutes, $A$ and $B$, coupled 1:1 from outside to inside. Assume dilute ideal solutions, a tenfold larger concentration of $A$ outside, and a fivefold larger concentration of $B$ inside. Their combined free energy change iswhich is negative. Favorable inward movement of $A$ can therefore pay for inward movement of $B$ against its concentration gradient. Charged substrates require additional electrical terms; the toy calculation is not a measured stoichiometry of the kidney transporters.

Wee1 is a protein kinase that inhibits CDK1 by adding a phosphate group at an inhibitory site. Purified human Wee1 phosphorylated Cdc2 at Tyr15 in the reported in vitro assay, with no Thr14 modification detected. A catalytic-site mutation abolished both the measured protein kinase activity and the ability to inhibit division. This identifies a catalytic brake rather than merely a correlated protein amount.^[ref]

Do not attribute all inhibitory CDK1 phosphorylation to Wee1: the Xenopus laevis Myt1 experiment separately identified activity toward both Thr14 and Tyr15. Nor does every phosphorylation inhibit its target: activating Thr161 modification in the studied Xenopus laevis Cdc2 has the opposite role. In cell-cycle activation feedback, suppression of Wee1 removes a brake on CDK1, reinforcing the transition without implying that the total amount of either protein instantly disappears.

Xenopus is a taxonomic genus of African clawed frogs used in experimental biology. Xenopus laevis is an important example. Its large egg cells and oocytes make manipulations of individual cells possible, allowing researchers to change a defined component and observe development or membrane function.

In John Gurdon's 1962 somatic cell nuclear transfer experiments, nuclei from intestinal epithelium of feeding tadpoles were introduced into eggs whose own nuclear contribution had been removed. A nuclear marker helped identify the donor origin, while embryonic-nucleus controls tested whether the recipient eggs and procedure could support development. Successful development showed that differentiation did not necessarily eliminate the nuclear information needed for other cell types.^[ref]

A different use treats the oocyte as a test cell for a cloned membrane protein. The 1993 aquaporin-2 study introduced the channel's RNA into Xenopus oocytes and measured the resulting increase in water permeability. Comparing injected and control cells turns swelling in a defined external solution into evidence that a candidate protein can provide a pathway for water across a cell membrane.^[ref]

Xenopus laevis is a frog used in developmental biology, including the intestinal nucleus transfer experiment and Xenopus laevis egg extract preparations.